InvestorsHub Logo

$heff

05/16/16 8:40 AM

#93953 RE: $heff #93852

$ADRO Ph2b pancreatic cancer data #FAIL
Http://www.finance.yahoo.com/news/aduro-bio…

CRS-207 + GVAX combo did worse than chemo: 3.8mo vs 4.6mo mOS (h/t @andybiotech)

$ADXS technology is no good after the $ADRO data release.